Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)

Market Cap	10.65B
Revenue (ttm)	6.79B
Net Income (ttm)	880.50M
Shares Out	178.70M
EPS (ttm)	4.92
PE Ratio	12.11
Forward PE	11.46
Dividend	2.80 (4.71%)
Ex-Dividend Date	Aug 1, 2024

Volume	80,953
Average Volume	152,667
Open	59.60
Previous Close	59.40
Day's Range	59.30 - 59.80
52-Week Range	51.20 - 79.40
Beta	0.07
RSI	56.35
Earnings Date	May 7, 2025

About TPE:1720

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan and internationally. The company offers various pharmaceutical products for metabolic, respiratory, musculoskeletal, digestive, circulatory system, topical dermatological, cardiovascular system, anti-infectives, urogenital system and sex hormones, and others. It engages in processing, manufacturing, and selling of food; and offers western medicine, nourishment, and function food, biochemical nutrition, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2024, TPE:1720's revenue was 6.79 billion, an increase of 8.81% compared to the previous year's 6.24 billion. Earnings were 880.50 million, an increase of 5.46%.